Aurelio, Mario H.
HRN: 24-47-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2024
CEFTAZIDIME 1GM (VIAL)
02/22/2024
02/29/2024
IV
1 Gram
Q24hrs
S/p Bka, Left
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes